C9orf129

mutation — cross-omics
Cross-omicsMUTATION → IMMUNEPatientPairwise association · TCGA cohorts

Across TCGA patient cohorts, C9orf129 mutation is significantly associated with the immune_cell of many other genes, with 3 significant associations in total. UCEC shows the largest number of these associations.

The most reproducible C9orf129-associated genes across cancer lineages are CD8+ Tem, lymphatic Endothelial cells, and mv Endothelial cells. Each is linked with C9orf129 in more than 1 cancer types. Because this analysis shows association rather than direction, both C9orf129-to-partner and partner-to-C9orf129 results are reported.

Each partner links to its own Q-omics profile.

mutation associated genes by consensus

Ranked by combined sampling and lineage consensus. X-score (C9orf129→partner) and Y-score (partner→C9orf129) are standardized regression coefficients; both directions are reported because the association is undirected. p-values are from the association test.
LineagePartner geneX-scoreY-scorep(X)p(Y)Sampling consensusLineage consensus
UCECCD8+ Tem →+0.001+4.744.010.04031
UCEClymphatic Endothelial cells →-0.025-3.268.043.01131
UCECmv Endothelial cells →-0.029-3.000.017.03631
Each partner links to its Q-omics profile. Showing the 3 strongest of 3 associations by consensus.

Exploration